Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methionine Sulfoxide SCHEMBL38627 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL14448373 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL995666 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL689456 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL38626 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL689512 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL4418369 | 1.00 | GSR (0.46) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL22076611 | 0.98 | GSR (0.45) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL28993578 | 0.96 | GGT1 (0.44) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Methionine Sulfoxide SCHEMBL16176754 | 0.94 | GSR (0.42) | GSRGRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637420-B2 | Method for separation of methionine sulfoxide diastereomers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-26 | — | — | US | claimed |
| US-20220064216-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2022-03-03 | — | — | US | claimed |
| US-20220054583-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2022-02-24 | — | — | US | claimed |
| EP-3849582-A1 | PEPTIDES AND MEDICAL USES THEREOF | Anbition S.r.l. (IT) | 2021-07-21 | — | — | EP | claimed |
| EP-3849583-A1 | PEPTIDES AND MEDICAL USES THEREOF | Anbition S.r.l. (IT) | 2021-07-21 | — | — | EP | claimed |
| CN-113015539-A | Peptides and medical uses thereof | 安必圣有限责任公司 | 2021-06-22 | — | — | CN | claimed |
| CN-112996528-A | Peptides and medical uses thereof | 安必圣有限责任公司 | 2021-06-18 | — | — | CN | claimed |
| WO-2020053773-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2020-03-19 | — | — | WO | claimed |
| WO-2020053772-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2020-03-19 | — | — | WO | claimed |
| US-9695191-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2017-07-04 | — | — | US | claimed |
| EP-2036918-A1 | PEPTIDE DERIVATIVE | Vexon, Inc. (JP) | 2009-03-18 | — | — | EP | claimed |
| US-20080009448-A1 | Peptide Derivative | VEXON, INC. (50%) (JP) | 2008-01-10 | — | — | US | claimed |
| EP-0850950-A1 | PEPTIDE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1998-07-01 | — | — | EP | claimed |
| US-4337247-A | ANALGESICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-29 | — | — | US | claimed |
| EP-0005248-B1 | TETRAPEPTIDEHYDRAZIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | Takeda Chemical Industries, Ltd. (JP) | 1982-03-24 | — | — | EP | claimed |
| EP-0031567-A2 | Tetrapeptidesemicarbazide derivatives and their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-07-08 | — | — | EP | claimed |
| US-4277394-A | ANALGESICS, ANTIDIARRHEA, TREATMENT OF MENTAL DISEASE | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 1981-07-07 | — | — | US | claimed |
| US-4199568-A | Tetrapeptide amides | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1980-04-22 | — | — | US | claimed |
| US-4178371-A | ANALGESIC, NARCOTIC ANTAGONIST OR ANTIDIARRHEAL AGENT | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1979-12-11 | — | — | US | claimed |
| EP-0005248-A2 | Tetrapeptidehydrazide derivatives and process for their preparation | Takeda Chemical Industries, Ltd. (JP) | 1979-11-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064216-A1 | PEPTIDES AND MEDICAL USES THEREOF | FLT1, FLT4, TEK | GSR 4206/4885GRM8 4331/4885GRM6 4353/4885 |
| US-20220054583-A1 | PEPTIDES AND MEDICAL USES THEREOF | FLT1, FLT4, TEK | GSR 4206/4885GRM8 4331/4885GRM6 4353/4885 |
| US-20080009448-A1 | Peptide Derivative | ARGLU1, NGLY1, NPR3 | GSR 4547/4885GRM8 2265/4885GRM6 2710/4885 |
| US-12637420-B2 | Method for separation of methionine sulfoxide diastereomers | MET, MGMT, MAT2B | GSR 40/4885GRM8 1743/4885GRM6 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.